And each time I debunk it. :D
For Immediate Release
Contact: Jennifer Brindise (202) 496-5015
January 2, 2003
Society Applauds FDA's Choice of Leadership for Reproductive Health Drugs Advisory Panel
New FDA Committee Chair Member of Society's Board
Washington, D.C. - The Society for Women's Health Research praises the Food and Drug Administration's recent leadership selection to its Advisory Committee for Reproductive Health Drugs.
Linda C. Giudice, M.D., Ph.D., chief of reproductive endocrinology and infertility in the department of gynecology and obstetrics at Stanford University Medical Center, was named chair of the committee in late December.
"The Society is encouraged by the FDA's choice of a leader who has outstanding medical, research and academic credentials, and who brings both scientific objectivity and concern for the welfare of all women to the position," said Roberta Biegel, government relations director of the Society, which recommended Giudice to the FDA.
http://www.womens-health.org/0javascripts/dropinnav.htm?/press/Releases/giudice.htm